Skip to main content

Peer Review reports

From: PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma

Original Submission
28 Oct 2020 Submitted Original manuscript
10 Mar 2021 Author responded Author comments - David James Pinato
Resubmission - Version 2
10 Mar 2021 Submitted Manuscript version 2
15 Mar 2021 Editorially accepted
23 Mar 2021 Article published 10.1186/s12885-021-08033-x

You can find further information about peer review here.

Back to article page